Advertisement
Screener

WEST PHARMACEUTICAL SERVICES, INC. (WST) ROA

WEST PHARMACEUTICAL SERVICES INC ROA

Return on assets (ROA) is the profit a company earns for every dollar of assets it uses, shown as a percentage. It is net income divided by total assets, and the table shows both amounts. Because assets are funded by lenders as well as shareholders, ROA is not inflated by borrowing the way ROE can be, and it is naturally lower for businesses that need many factories, stores or other assets. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • WEST PHARMACEUTICAL SERVICES INC roa for the quarter ending 2020-03-31 was 11.60%, a 8.00% increase year-over-year.
  • WEST PHARMACEUTICAL SERVICES INC roa for the quarter ending 2019-12-31 was 10.32%, a 1.27% decline year-over-year.
  • WEST PHARMACEUTICAL SERVICES INC roa for the quarter ending 2019-09-30 was 10.57%, a 32.80% increase year-over-year.
  • WEST PHARMACEUTICAL SERVICES INC roa for the quarter ending 2019-06-30 was 10.77%, a 33.93% increase year-over-year.
  • WEST PHARMACEUTICAL SERVICES INC roa for fiscal 2019 was 10.32%, a 1.27% decline from fiscal 2018.
  • WEST PHARMACEUTICAL SERVICES INC roa for fiscal 2018 was 10.46%, a 29.24% increase from fiscal 2017.
  • WEST PHARMACEUTICAL SERVICES INC roa for fiscal 2017 was 8.09%, a 3.29% decline from fiscal 2016.
  • WEST PHARMACEUTICAL SERVICES INC roa for fiscal 2016 was 8.36%, a 48.32% increase from fiscal 2015.
Available history
2009-12-31 to 2020-03-31
Data captured

Historical ROA

DateROANet income 12 monthNet income 3 monthTotal assets
2020-03-3111.60%$260.6M$74.30M$2.25B
2019-12-3110.32%$241.7M$63.90M$2.34B
2019-09-3010.57%$229.8M$56.30M$2.17B
2019-06-3010.77%$228.7M$66.10M$2.12B
2019-03-3110.74%$218.7M$55.40M$2.04B
2018-12-3110.46%$206.9M$1.98B
2018-09-307.96%$154.9M$1.95B
2018-06-308.04%$150.7M$1.87B
2018-03-317.14%$133.4M$1.87B
2017-12-318.09%$150.7M$1.86B
2017-09-309.83%$189.8M$1.93B
2017-06-309.57%$176.4M$1.84B
2017-03-3110.52%$182.3M$1.73B
2016-12-318.36%$143.5M$1.72B
2016-09-307.94%$137.8M$1.74B
2016-06-305.96%$101.7M$1.71B
2016-03-315.08%$84.8M$1.67B
2015-12-315.64%$95.6M$1.7B
2015-09-305.62%$93.6M$1.67B
2015-06-307.40%$123.1M$1.66B
2015-03-318.33%$132.9M$1.6B
2014-12-317.61%$127.1M$1.67B
2014-09-307.13%$119.3M$1.67B
2014-06-306.75%$115.1M$1.7B
2014-03-316.30%$107.7M$1.71B
2013-12-316.72%$112.3M$1.67B
2013-09-306.60%$109.8M$1.66B
2013-06-306.06%$97.8M$1.61B
2013-03-315.28%$83.2M$1.58B
2012-12-315.16%$80.7M$1.56B
2012-09-305.13%$78.4M$1.53B
2012-06-305.50%$80.5M$1.46B
2012-03-315.83%$85M$29.20M$1.46B
2011-12-315.39%$75.4M$1.4B
2011-09-304.48%$62.6M$16.90M$1.4B
2011-06-304.49%$63.5M$20.10M$1.42B
2011-03-314.77%$65.1M$19.60M$1.37B
2010-12-315.05%$65.3M$6.00M$1.29B
2010-09-306.12%$79.6M$17.80M$1.3B
2010-06-306.46%$79M$21.70M$1.22B

Annual ROA

DateROANet income 12 monthTotal assets
2019-12-3110.32%$241.7M$2.34B
2018-12-3110.46%$206.9M$1.98B
2017-12-318.09%$150.7M$1.86B
2016-12-318.36%$143.6M$1.72B
2015-12-315.64%$95.6M$1.7B
2014-12-317.61%$127.1M$1.67B
2013-12-316.72%$112.3M$1.67B
2012-12-315.16%$80.7M$1.56B
2011-12-315.40%$75.5M$1.4B
2010-12-315.05%$65.3M$1.29B
2009-12-315.71%$72.6M$1.27B

Similar stocks

Stock NameCountryMarket CapPE Ratio
DEXCOM INC (DXCM)United States$33.004B25.42
Solventum Corp (SOLV)United States$15.085B9.16
Penumbra Inc (PEN)United States$12.596B77.33
BAXTER INTERNATIONAL INC (BAX)United States$12.139B-10.35
GLOBUS MEDICAL INC (GMED)United States$9.977B20.03
INSULET CORP (PODD)United States$9.420B28.12
GLAUKOS Corp (GKOS)United States$9.135B-43.73
MiniMed Group, Inc. (MMED)United States$5.748B-16.85
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44
TELEFLEX INC (TFX)United States$5.093B-5.44